BioNTech
BNTX
BNTX
279 hedge funds and large institutions have $4.55B invested in BioNTech in 2025 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less call options, than puts
Call options by funds: $138M | Put options by funds: $142M
8% less capital invested
Capital invested by funds: $4.97B → $4.55B (-$420M)
Holders
279
Holding in Top 10
3
Calls
$138M
Puts
$142M
Top Buyers
| 1 | +$117M | |
| 2 | +$49.2M | |
| 3 | +$48.4M | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$47.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$44.1M |
Top Sellers
| 1 | -$668M | |
| 2 | -$164M | |
| 3 | -$45.8M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$36.9M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$35.2M |
